Aquestive疗法

AQST NASDAQ
4.130
-0.140
-3.28%
已收盘, 16:00 07/17 EDT
开盘
4.300
昨收
4.270
最高
4.300
最低
4.000
成交量
6.35万
成交均量(3M)
13.15万
52周最高
20.70
52周最低
3.650
换手率
0.26%
市值
9,912.00万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Aquestive疗法 AQST股票价格,Aquestive疗法股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. Libervant is a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures. Sympazan is an oral soluble film formulation of clobazam for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut Syndrome. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The Company’s complex molecule programs consist of AQST-108, and AQST-305, for the treatment of anaphylaxis and neuroendocrine tumors respectively. The Company also has a pipeline of products under partner programs, which includes Suboxone and APL-130277 for the treatment of opioid dependence, and Parkinson’s disease.
展开 >

最近浏览

名称
价格
涨跌幅